Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population

Pharmacotherapy

Volumn 36, Issue 3, 2016, Pages 348-356

  Maxwell, Lauralee G ^a   McFarland, Michael Shawn ^a   Baker, Jennifer Waymier ^a   Cassidy, Regina F ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

hemoglobin A1c; hyperlipidemia; hypertension; pharmacist; telemedicine; type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FISH OIL; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; VASODILATOR AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PHARMACY; CLINICAL PHARMACY SPECIALIST; CLINICAL VIDEO TELEHEALTH; COHORT ANALYSIS; COMMUNITY BASED OUTPATIENT CLINIC; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH CARE FACILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MALE; PATIENT SATISFACTION; PHARMACIST; PILOT STUDY; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TELEHEALTH; TELEMEDICINE; UNITED STATES; VETERAN; BLOOD; BLOOD PRESSURE; DRUG EFFECTS; ORGANIZATION AND MANAGEMENT; PROCEDURES; STATISTICS AND NUMERICAL DATA; TELECONSULTATION; TENNESSEE;

BLOOD PRESSURE; CHOLESTEROL, LDL; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PATIENT SATISFACTION; PHARMACISTS; PILOT PROJECTS; PROSPECTIVE STUDIES; REMOTE CONSULTATION; TELEMEDICINE; TENNESSEE; VETERANS;

EID: 84960453365     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1719     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2014.
2. Miller DR, Safford MM, Pogach LM,. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004; 27: B10-21.
3. Centers for Disease Control and Prevention. The Burden of Chronic Diseases and Their Risk Factors: National and State Perspectives 2004. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, 2004. Available from http://www.cdc.gov/nccdphp/publications/AAG/dhdsphtm. Accessed July 7, 2012.
4. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38 (Suppl 1): S05-87.
5. Rosenthal TC,. The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med 2008; 21 (5): 427-40.
6. Steiner BD, Denham AC, Ashkin E, Newton WP, Wroth T, Dobson LA Jr,. Community care of North Carolina: improving care through community health networks. Ann Fam Med 2008; 6 (4): 361-7.
7. Bojadzievski T, Gabbay RA,. Patient-centered medical home and diabetes. Diabetes Care 2011; 34 (4): 1047-53.
8. Grumbach K, Bodenheimer T, Grundy P,. The outcomes of implementing patient-centered medical home interventions: A review of the evidence on quality, access and costs from recent prospective evaluation studies, August 2009. Available from www.pcpcc.net/files/evidenceWEB%20FINAL%2010.16.09-1.pdf. Accessed July 16, 2012.
9. McCord AD,. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy 2006; 26 (2): 248-53.
10. Cripps RJ, Gourley ES, Johnson W, et al., An evaluation of diabetes measures of control after 6 months of clinical pharmacy specialist intervention. J Pharm Pract 2011; 24 (3): 332-8.
11. McFarland MS, Davis KJ, Wallace JL,. Utilization of home telehealth monitoring with active medication management by clinical pharmacists in poorly controlled diabetics. Pharmacotherapy 2012; 32 (5): 420-6.
12. Health Resources and Services Administration. U.S. Department of Health and Human Services. Telehealth. Available from http://www.hrsa.gov/ruralhealth/about/telehealth. Accessed June 19, 2012
13. Franc S, Daoudi A, Mounier S, et al., Telemedicine and diabetes: achievements and prospects. Diabetes Metab 2011; 37: 463-76.
14. Franc S, Daoudi A, Mounier S, et al., Telemedicine: what more is needed for its integration in everyday life? Diabetes Metab 2011; 37: S71-7.
15. Rothman RL, Malone R, Bryant B, et al., A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005; 118 (3): 276-84.
16. VA Telehealth Services. Available from http://www.telehealth.va.gov/. Accessed December 2, 2015.
17. Siriwardena AN, Wickramasinghe AS, Perera LD, Marasinghe RB, Katulanda P, Hewapathirana R,. A review of telemedicine interventions in diabetes care. J Telemed Telecare 2012; 18 (3): 164-8.
18. Whitlock WL, Brown A, Moore K, et al., Telemedicine improved diabetes management. Mil Med 2000; 165: 579-84.
19. Timmerberg BD, Wurst J, Patterson J, Spaulding RJ, Belz NE,. Feasibility of using videoconferencing to provide diabetes education: A pilot study. J Telemed Telecare 2009; 15: 95.
20. Hernandez L, Chang CH, Cella D, et al., Development and validation of the satisfaction with pharmacists scale. Pharmacotherapy 2000; 20: 837-43.
21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837.
22. Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G,. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Care 2012; 35: 2706-17.
23. Ragucci KR, Fermo JD, Wessell AM, Chumney EC,. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy 2005; 25 (12): 1809-16.
24. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al., US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010; 48: 923-33.
25. Verhoeven F, Tanja-Dijkstra K, Nijland N, Eysenbach G, van Gemert-Pijnen L,. Asynchronous and synchronous teleconsultation for diabetes care: A systematic literature review. J Diabetes Sci Technol 2010; 4: 666-84.
26. Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR,. Linking primary care performance to outcomes of care. J Fam Pract 1998; 47 (3): 213-20.
27. Doyle C, Lennox L, Bell D,. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open 2013; 3 (1):e.001570. doi 10.1536/bmjopen-2012-001570
28. McFarland M, Wallace J, Parra J, Baker J,. Evaluation of patient satisfaction with diabetes management provided by clinical pharmacists in the patient-centered medical home. Patient 2014; 7 (1): 115-21.
29. Nwankwo T, Yoon SS, Burt V, Gu Q,. Hypertension among adults in the US: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief, No. 133. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2013.
30. Mozzafarian D, Benjamin EJ, Go AS, et al., Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015; 131: e29-322. DOI: 10.1161/CIR.0000000000000152.
31. Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol. United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 2011; 60 (4): 109-14.